<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-06-29)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-06-29)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Sources say FDA commissioner sought rejection of KalVista’s rare disease drug; FDA looks into Sarepta’s Duchenne therapy after deaths; and more</h3>
<p class='source-date'><em>Endpoints News • 2025-06-28</em></p>
<p>Welcome back to Endpoints Weekly! Thanks for spending your Saturday with us. We start this week’s recap with reporting from Endpoints News’ senior biopharma correspondent Andrew Dunn on the FDA’s review of KalVista Pharmaceuticals’ rare ...</p>
<p><a href='https://endpoints.news/sources-say-fda-commissioner-sought-rejection-of-kalvistas-rare-disease-drug-fda-looks-into-sareptas-duchenne-therapy-after-deaths-and-more/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Vetter Begins Construction of Clinical Manufacturing Site in Illinois</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-27</em></p>
<p>Upstream and ground preparation work on the premises started back in April. Vetter’s construction plans include a 160,000-sq-ft clinical production facility for aseptic manufacturing and new process areas for material preparation. The post Vetter Begins Construction of Clinical Manufacturing Site...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/vetter-begins-construction-of-clinical-manufacturing-site-in-illinois/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Severe Epileptic Encephalopathy Linked to Citrate Transporter Mutations</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-27</em></p>
<p>Experimental analysis of 38 mutant variants of the membrane transporter SLC13A5 sheds light on its function and structure, revealing mechanisms that may underlie a severe form of epileptic encephalopathy associated with its dysfunction. The post Severe Epileptic Encephalopathy Linked to Citrate T...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/severe-form-of-epileptic-encephalopathy-linked-to-mutations-in-citrate-transporter/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Accelerating In Vivo CAR-T Development Using Single Nanoparticle Characterization</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-27</em></p>
<p>In this GEN webinar, Joseph Brealey, an expert in nanoparticle delivery, will discuss current strategies for improving quality control of in vivo CAR T therapies. The post Accelerating In Vivo CAR-T Development Using Single Nanoparticle Characterization appeared first on GEN - Genetic Engineering...</p>
<p><a href='https://www.genengnews.com/multimedia/webinars/accelerating-in-vivo-car-t-development-using-single-nanoparticle-characterization/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Genetic “Dimmer Switch” Offers Precise Gene Expression Control</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-27</em></p>
<p>Using CRISPR-Cas9 gene editing, the team systematically dissected the regulatory landscape around the Cdx2 gene. They found a DNA element that modifies expression with temporal and tissue specificity which can also be reprogrammed. The post Genetic “Dimmer Switch” Offers Precise Gene Expression C...</p>
<p><a href='https://www.genengnews.com/topics/genome-editing/genetic-dimmer-switch-offers-precise-gene-expression-control/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Mice Regenerate Ear Tissue When Vitamin A Genetic Switch is Flipped</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-06-27</em></p>
<p>By flipping an evolutionarily disabled genetic switch involved in retinoic acid metabolism, or by administering exogenous retinoic acid, researchers have enabled ear tissue regeneration in mice. The post Mice Regenerate Ear Tissue When Vitamin A Genetic Switch is Flipped appeared first on GEN - G...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/mice-regenerate-ear-tissue-when-vitamin-a-genetic-switch-is-flipped/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Safety Assessment of GABA-Producing Levilactobacillus brevis LAB6 MTCC 25662 and Its Anti-inflammatory Effects in Murine Macrophages.</h4>
<p class='source-date'><em>Matta Tushar, Agrawal Kushhagra, Datta Priyanshi et al. | Probiotics and antimicrobial proteins • 2025-06-27</em></p>
<p><strong>Abstract:</strong> To ascertain safety, the assessment of bacterial strains to be used as probiotics needs rigorous and well-designed in vitro and in vivo studies. Here, the safety of a GABA-producing Levilactobacillus brevis LAB6 MTCC 25662 was assessed using in (silico, vitro and vivo) approaches. Firstly, the ge...</p>
<p><a href='https://doi.org/10.1007/s12602-025-10628-w' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment.</h4>
<p class='source-date'><em>Gupta Mandeep Kumar, Chauhan Kanupriya, Bhardwaj Snigdha et al. | Probiotics and antimicrobial proteins • 2025-06-27</em></p>
<p><strong>Abstract:</strong> Neurodegenerative disorders, including Huntington's disease, Amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease, create more challenges as the population gets older and there are no curative therapies available. Recent advances in gut microbiome research have spotlighted ...</p>
<p><a href='https://doi.org/10.1007/s12602-025-10632-0' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Clinical trial landscape for pneumonia: Evolving agents against bacterial pathogens.</h4>
<p class='source-date'><em>Feng Du, Jiang Huixin, Deng Hao et al. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases • 2025-06-25</em></p>
<p><strong>Abstract:</strong> Pneumonia remains a significant global health challenge, exacerbated by the escalating crisis of antimicrobial resistance. Through a comprehensive analysis of clinical trials spanning three decades, this study reveals the evolving landscape of anti-pneumonia drug development. Through analysis of ...</p>
<p><a href='https://doi.org/10.1016/j.ijid.2025.107965' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Piper Kadsura Extract and its Bioactive Components Attenuates Aβ</h4>
<p class='source-date'><em>Ye Kaili, Zeng Mengnan, Zhang Beibei et al. | Neurochemical research • 2025-06-27</em></p>
<p><strong>Abstract:</strong> Piper kadsura (Choisy) Ohwi, a traditional medicinal plant used in East Asia, is renowned for its anti-inflammatory and antioxidant properties. Its bioactive components, such as Hancinone and Futoquinol, show potential in treating neurodegenerative disorders like Alzheimer's disease (AD). Aim of ...</p>
<p><a href='https://doi.org/10.1007/s11064-025-04433-8' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A Multilayered Biocontainment System for Laboratory and Probiotic Yeast.</h4>
<p class='source-date'><em>Maneira Carla, Becker Sina, Chamas Alexandre et al. | Metabolic engineering • 2025-06-25</em></p>
<p><strong>Abstract:</strong> The containment of genetically engineered microorganisms to designated environments of action is a paramount step in preventing their spread to nature. Physical barriers were traditionally employed to solve this issue, nevertheless, the growing number of biotechnological operations in open dynami...</p>
<p><a href='https://doi.org/10.1016/j.ymben.2025.06.009' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Gut bacteriophages induce specific-reprogramming of macrophages to generate a protective innate immunity response to lipopolysaccharide exposure.</h4>
<p class='source-date'><em>Hou Xiang, Ding Huiyan, Wang Heye et al. | Gut microbes • 2025-12-01</em></p>
<p><strong>Abstract:</strong> Macrophages play essential roles in generating a tolerogenic resident environment, but the interactions between bacteriophages and their action in macrophage tolerance memory remain unknown. Here, we find that gut bacteriophage exposure</p>
<p><a href='https://doi.org/10.1080/19490976.2025.2524540' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Identification of Lytic Enzymes With Activity Against Corynebacterium Species.</h4>
<p class='source-date'><em>Mixon Monica A, Paskaleva Elena E, Luong Sheila et al. | Biotechnology and bioengineering • 2025-06-26</em></p>
<p><strong>Abstract:</strong> Corynebacteriales are normal constituents of the human skin microbiota, involved in the metabolism of sweat and sebaceous glands secretions. The resultant compounds are a source of human body malodor. Some species, such as Corynebacterium jeikeium, are also opportunistic pathogens, and can cause ...</p>
<p><a href='https://doi.org/10.1002/bit.70009' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Clinical trial landscape for pneumonia: Evolving agents against bacterial pathogens.</h4>
<p class='source-date'><em>Feng Du, Jiang Huixin, Deng Hao et al. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases • 2025-06-25</em></p>
<p><strong>Abstract:</strong> Pneumonia remains a significant global health challenge, exacerbated by the escalating crisis of antimicrobial resistance. Through a comprehensive analysis of clinical trials spanning three decades, this study reveals the evolving landscape of anti-pneumonia drug development. Through analysis of ...</p>
<p><a href='https://doi.org/10.1016/j.ijid.2025.107965' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Responses of viral communities in aerobic biofilms under antibiotic stress.</h4>
<p class='source-date'><em>Wang Chen, Luan Xiao, Zhang Junya et al. | Water research • 2025-06-24</em></p>
<p><strong>Abstract:</strong> Bacteriophages are pivotal in shaping microbial communities, but their structural and functional responses to antibiotic stress in aerobic biofilms remain underexplored. This study aims to fill this void by providing a comprehensive understanding of how viral communities in aerobic biofilms adapt...</p>
<p><a href='https://doi.org/10.1016/j.watres.2025.124099' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>From Precision Synthesis to Cross-Industry Applications: The Future of Emerging Peptide Technologies.</h4>
<p class='source-date'><em>Wang Mingming, Xia Hongmin, Wang Cheng et al. | Pharmacological research • 2025-06-25</em></p>
<p><strong>Abstract:</strong> Peptides, derived primarily from natural bioactive sources, play essential roles in human physiological processes such as hormone regulation and nerve signal transmission. Recent advances in phage display technology have revolutionized peptide screening, enabling the rapid and efficient identific...</p>
<p><a href='https://doi.org/10.1016/j.phrs.2025.107839' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2025-06-29</em></p>
</div>
</body>
</html>